Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (18)

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

2022

  1. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

    European Respiratory Journal

  2. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis

    Immunotherapy, Vol. 14, Núm. 9, pp. 683-694

  3. Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 5, pp. 345-356

2021

  1. Seaic specialty forum: Analysis of the current situation of allergology in spain and outlook for the future

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 120-131

2019

  1. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study

    Breast, Vol. 46, pp. 108-115

2018

  1. Asthma exacerbations: risk factors for hospital readmissions

    Irish Journal of Medical Science, Vol. 187, Núm. 1, pp. 155-161

  2. Safety and Quality Recommendations in Allergy Medicine (Spanish acronym, RESCAL)

    Journal of investigational allergology & clinical immunology, Vol. 28, pp. 1-39

2017

  1. Differences Between Alcoholic and Nonalcoholic Patients With Wernicke Encephalopathy: A Multicenter Observational Study

    Mayo Clinic Proceedings, Vol. 92, Núm. 6, pp. 899-907

2016

  1. Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies

    Clinical and Translational Allergy, Vol. 6, Núm. 1

2014

  1. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus

    Clinical and Translational Allergy, Vol. 4, Núm. 1

2013

  1. Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002

  2. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

  2. Diagnosis and treatment of allergic rhinitis due to house-dust mites in Spain

    American Journal of Rhinology and Allergy, Vol. 26, Núm. 1, pp. 23-26

  3. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

2011

  1. Age-related macular degeneration: Analysis of the results of ranibizumab therapy

    Medicina Clinica

1996

  1. A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals

    Antiviral Therapy, Vol. 1, Núm. 2, pp. 105-112